LataMed AI Partners with IVIC to Develop Digital Platform for Laboratory Services in Venezuela

LataMed AI Corp. (OTC: LMED), a healthcare technology company focused on digital health and artificial intelligence solutions for Latin America, announced on July 31, 2026, that its Venezuelan subsidiary, LATAMEDAI VE, has entered into an agreement with the Venezuelan Institute for Scientific Research (IVIC) to develop a digital platform module. The module is intended to support access to designated laboratory and scientific services for authorized business and institutional users.

Under the agreement, LataMed AI and IVIC will collaborate on the design, development, testing, and implementation of a digital interface. This interface would allow authorized users to request available laboratory services, schedule appointments, monitor the status of submitted requests, access approved reports and documentation, and complete authorized payment-related processes. The proposed module aims to provide a centralized digital workflow for organizations seeking scientific and laboratory services in areas such as healthcare, pharmaceuticals, food production, agriculture, and related industries. The specific services made available will be determined by IVIC and implemented in accordance with technical, operational, security, and legal requirements established by the parties.

LataMed AI will begin working with IVIC to define the module’s functional requirements, user-access procedures, data architecture, payment workflows, document-management capabilities, and phased testing and implementation process. The parties will also establish procedures governing the handling, transmission, storage, and authorized access to laboratory-related information and documentation. The contemplated functionality may include electronic service requests, appointment scheduling, request-status tracking, secure payment facilitation, and controlled access to laboratory reports or other authorized documentation. The final functionality, implementation schedule, and scope of services remain subject to continued technical development, testing, and approval by the parties.

“This agreement represents an opportunity to apply our technology to an important area of scientific and enterprise service delivery,” said Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp. “Our objective is to work with IVIC to develop a responsible digital framework that makes it easier for authorized users to request services, manage appointments, monitor processes, and access approved information through a centralized platform.”

This initiative is significant because it expands LataMed AI’s capabilities beyond patient-facing telemedicine, demonstrating how its technology can support institutional and enterprise workflows involving healthcare, scientific services, laboratory coordination, and digital documentation. It aligns with the Company’s broader strategy of developing digital infrastructure connecting patients, healthcare professionals, pharmacies, insurers, payment providers, wellness organizations, institutions, and other participants in the healthcare and scientific-services ecosystem. If successfully implemented, management believes the module could provide a framework adaptable for other institutional and enterprise service environments in Venezuela and elsewhere in Latin America, though any future expansion would be subject to separate agreements and regulatory requirements.

The agreement establishes the framework for development and evaluation but does not guarantee a specific implementation date, user adoption, service volume, revenue, or profitability. LataMed AI will provide further updates as development progresses. For additional information, visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.